SUBSCRIBE
SUBSCRIBE

Cabaletta Bio

NEWS
Lymphocytes and biomedical concept, 3d rendering. 3D illustration.
Cell therapy
5 CAR T Cell Therapies With Autoimmune Readouts in 2025
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune disorders, with several early- to mid-stage readouts expected this year.
March 17, 2025
 · 
9 min read
 · 
Tristan Manalac
Washington DC, USA at the Tidal Basin during spring season at night.
Cell Therapy
CAR T for Lupus Takes Center Stage at ACR 2024
Investigational CAR T therapies stole the spotlight at the American College of Rheumatology Convergence as data presented by Bristol Myers Squibb, Kyverna Therapeutics and more highlighted their potential to effectively treat lupus.
November 19, 2024
 · 
4 min read
 · 
Kate Goodwin
IN THE PRESS
Press Releases
Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform
March 19, 2025
 · 
6 min read
Press Releases
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
February 26, 2025
 · 
1 min read
Press Releases
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 19, 2025
 · 
11 min read
Press Releases
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 18, 2025
 · 
11 min read
Press Releases
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
February 11, 2025
 · 
3 min read
Press Releases
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
January 30, 2025
 · 
1 min read
Press Releases
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
January 14, 2025
 · 
12 min read
Press Releases
Cabaletta Bio to Participate in Upcoming Investor Conferences in December
November 26, 2024
 · 
1 min read
Press Releases
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
November 18, 2024
 · 
16 min read
Press Releases
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
November 15, 2024
 · 
15 min read
Load More
JOBS